- Home
- CVKD vs PIII Comparison
CVKD vs PIII Comparison
Compare CVKD & PIII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CVKD | PIII |
|---|---|---|
| Founded | 2022 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Medical/Nursing Services |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.3M | 10.8M |
| IPO Year | 2022 | N/A |
Fundamental Metrics
Financial Performance| Metric | CVKD | PIII |
|---|---|---|
| Price | $8.30 | $2.12 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 3 |
| Target Price | ★ $32.00 | $16.25 |
| AVG Volume (30 Days) | 48.5K | ★ 109.8K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $14.85 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.91 | $0.15 |
| 52 Week High | $20.39 | $11.30 |
Technical Indicators
Market Signals| Indicator | CVKD | PIII |
|---|---|---|
| Relative Strength Index (RSI) | 62.07 | 42.44 |
| Support Level | $6.64 | $1.52 |
| Resistance Level | $8.79 | $2.85 |
| Average True Range (ATR) | 0.64 | 0.25 |
| MACD | 0.40 | 0.08 |
| Stochastic Oscillator | 87.03 | 21.51 |
Price Performance
Historical ComparisonAbout CVKD Cadrenal Therapeutics Inc.
Cadrenal Therapeutics Inc is developing tecarfarin, its drug candidate, for unmet needs in anticoagulation therapy. Tecarfarin is a late-stage novel oral and reversible anticoagulant (blood thinner) designed to prevent heart attacks, strokes, and deaths due to blood clots in patients with rare cardiovascular conditions requiring chronic anticoagulation.
About PIII P3 Health Partners Inc.
P3 Health Partners Inc is a patient-centered and physician-led population health management company. P3's model aggregates and supports the community's existing healthcare resources to build a network of community providers working together to deliver coordinated and integrated care to patients with a shared commitment to improving patient outcomes, lowering cost, and delivering experience for all.